+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Optimization of cisplatin doses in a testicular cancer patient with acute renal failure

Optimization of cisplatin doses in a testicular cancer patient with acute renal failure

Journal of Oncology Pharmacy Practice 17(3): 265-269

Although testicular cancers are highly curable malignancies, conventional cisplatin based therapy often causes important toxicities, not often easily manageable. Nephrotoxicity occurs in almost all patients, and is potentialized in patients suffering from renal failure. Monitoring of residual levels of unbound platinum was used to define guidelines for cisplatin administration. Monitoring of cisplatin was initiated in a patient treated for metastatic testicular cancer and acute renal failure. Reduced doses of cisplatin were first administered in conjunction with hemodialysis. Unbound and total platinum levels were determined by flameless atomic absorption spectrophotometry. The data found allowed us to adapt and increase sequentially cisplatin doses, accordingly with the renal function. Full regimen doses were eventually administered when useful renal function returned. This simple approach may be useful in monitoring cisplatin administration during acute renal failure.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036216096

Download citation: RISBibTeXText

PMID: 19933251

DOI: 10.1177/1078155209351761

Related references

Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Experimental and Toxicologic Pathology 61(6): 565-571, 2009

Severe acute renal failure after administration of contrast media in a patient treated with cisplatin. Nephrology Dialysis Transplantation 11(12): 2522-2523, 1996

The patient at risk for acute renal failure. Recognition, prevention, and preoperative optimization. Anesthesiology Clinics of North America 18(4): 705-717, 2000

Contrast media induced irreversible acute renal failure in a patient treated with intraperitoneal cisplatin. Clinical Nephrology 44(2): 135-136, 1995

Acute renal failure in an alcoholic patient taking therapeutic doses of acetaminophen. Journal of the American Board of Family Practice 11(5): 410-413, 1998

Associations between Clinical Factors and Acute Renal Failure Due to Cisplatin Combination Chemotherapy for Lung Cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(11): 1379-1383, 2015

Successful use of cisplatin to treat metastatic seminoma during cisplatin-induced acute renal failure. Cancer 68(8): 1720-1723, 1991

Acute renal failure associated with intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection in ovarian cancer patients. European Journal of Gynaecological Oncology 12(5): 403-406, 1991

Acquired resistance to acute renal failure in cisplatin-induced renal failure of rats. Nihon Jinzo Gakkai Shi 39(7): 728-733, 1997

Acute renal failure in the cancer patient. Cancer Bulletin 44(3): 192-196, 1992

Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer. Medical Oncology 23(3): 419-422, 2006

Renal cell fate following cisplatin -induced acute renal failure. Journal of the American Society of Nephrology 7(9): 1842, 1996

Possible involvement of galectin-1 in renal tubular regeneration of cisplatin-induced acute renal failure. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 545A, 2002

Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. American Journal of Physiology 249(4 Pt 2): F490-F496, 1985

Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug and Chemical Toxicology 25(1): 1-8, 2002